Literature DB >> 2340359

Determination of bambuterol, a prodrug of terbutaline, in plasma and urine by gas chromatography/mass spectrometry.

C Lindberg1, S Jönsson, J Paulson, A Tunek.   

Abstract

(R,S)-Bambuterol was isolated from plasma and urine by solid-phase extraction and analysed as its trimethylsilyl derivative by gas chromatography/chemical ionization mass spectrometry with ammonia as the reagent gas. Deuterium-labelled bambuterol was used as internal standard. An esterase inhibitor was added to plasma to prevent hydrolysis of bambuterol in the plasma sample. Bambuterol could be measured in plasma down to 1 nmol l-1 with a within-day variation of less than 5% (coefficient of variation). The lower limit of measurement in urine was judged to be 8 nmol l-1, a concentration at which the within-day variation was 5.4% (coefficient of variation).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2340359     DOI: 10.1002/bms.1200190403

Source DB:  PubMed          Journal:  Biomed Environ Mass Spectrom        ISSN: 0887-6134


  6 in total

1.  Pharmacokinetics of bambuterol during oral administration to asthmatic children.

Authors:  H Ahlström; J Alvero; R Alvero; R Espos; L Fajutrao; J Herrera; B Kjellman; J Kubista; C Leviste; P Meyer; G Oldaeus; A Siricururat; P Vichyanond; G Wettrell; E Wong; L Laxmyr; L Nyberg; H Olsson; E Weibull; J Rosenborg
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

2.  Bambuterol and terbutaline in human cerebrospinal fluid and plasma.

Authors:  B Rosberg; C Schröder; L Nyberg; J Rosenborg; J E Wirén
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Pharmacokinetics of bambuterol during oral administration of plain tablets and solution to healthy adults.

Authors:  J Rosenborg; P Larsson; L Nyberg
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

4.  Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase.

Authors:  U Bang; L Nyberg; J Rosenborg; J Viby-Mogensen
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

5.  Pharmacokinetics of bambuterol in healthy subjects.

Authors:  L Nyberg; J Rosenborg; E Weibull; S Jönsson; B M Kennedy; M Nilsson
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

6.  Synchronous fluorescence as a green and selective tool for simultaneous determination of bambuterol and its main degradation product, terbutaline.

Authors:  Samah Abo El Abass; Heba Elmansi
Journal:  R Soc Open Sci       Date:  2018-10-31       Impact factor: 2.963

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.